Summit Financial, LLC Eli Lilly & CO Transaction History

Summit Financial, LLC

$2.54 Billion
Q3 2024

A detailed history of Summit Financial, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Summit Financial, LLC holds 6,484 shares of LLY stock, worth $5.05 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

6,484

Previous 8,374 22.57%

Holding current value

$5.05 Million

Previous $7.58 Million 24.23%

% of portfolio

0.23%

Previous 0.35%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $1.46 Million - $1.81 Million	-1,890 Reduced 22.57%	6,484 $5.74 Million
Q2 2024 Jul 31, 2024	BUY	$724.87 - $909.04 $4.31 Million - $5.4 Million	5,939 Added 243.9%	8,374 $7.58 Million
Q1 2024 Apr 24, 2024	SELL	$592.2 - $792.28 $204,309 - $273,336	-345 Reduced 12.41%	2,435 $1.89 Million
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $92,433 - $108,966	-176 Reduced 5.95%	2,780 $1.62 Million
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $3.27 Million - $4.5 Million	-7,516 Reduced 71.77%	2,956 $1.59 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $2.45 Million - $3.27 Million	6,982 Added 200.06%	10,472 $4.91 Million
Q1 2023 May 03, 2023	BUY	$310.63 - $364.82 $287,643 - $337,823	926 Added 36.12%	3,490 $1.2 Million
Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $73,313 - $85,424	228 Added 9.76%	2,564 $938,000
Q3 2022 Nov 15, 2022	BUY	$296.48 - $337.87 $376,529 - $429,094	1,270 Added 119.14%	2,336 $755 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $3,344 - $3,927	-12 Reduced 1.11%	1,066 $345,000
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $234 - $291	1 Added 0.09%	1,078 $308,000
Q4 2021 Feb 07, 2022	BUY	$224.85 - $279.04 $242,163 - $300,526	1,077 New	1,077 $297,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial, LLC with notifications on news.

Account

Summit Financial, LLC Eli Lilly & CO Transaction History